Epigallocatechin-3-Gallate (EGCG) Ameliorates Ineffective Hematopoiesis of Myelodysplasia Syndrome (MDS)

被引:0
|
作者
Della Via, Fernanda Isabel [1 ]
Ferro, Karla Priscila [2 ]
Assis-Mendonca, Guilherme Rossi [3 ]
Santos, Irene [1 ]
Amor, Nadia Ghinelli [1 ]
Pericole, Fernando Vieira [4 ]
De Prax, Marisa Claudia [4 ]
Olalla Saad, Sara Teresinha [1 ]
机构
[1] Univ Estadual Campinas, Hematol & Transfus Med Ctr Hemoctr, Campinas, Brazil
[2] Univ Estadual Campinas, Hematol & Transfus Med Ctr, Hemoctr, Hemoctr,UNICAMP, Campinas, Brazil
[3] Univ Estadual Campinas, Sch Med Sci, Dept Pathol, UNICAMP, Campinas, Brazil
[4] Hemoctr Unicamp, Campinas, Brazil
关键词
D O I
10.1182/blood-2023-186607
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid
    Ran, Zhi Hua
    Chen, Chi
    Xiao, Shu Dong
    BIOMEDICINE & PHARMACOTHERAPY, 2008, 62 (03) : 189 - 196
  • [42] Epigallocatechin and epigallocatechin-3-gallate are not inhibitors of tyrosinase
    Gasowska-Bajger, Beata
    Wojtasek, Hubert
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 113
  • [43] The Potential of Epigallocatechin-3-gallate (EGCG) as Complementary Medicine for the Treatment of Inflammatory Bowel Disease
    Schnur, Sabrina
    Hans, Fabian
    Dehne, Annika
    Osti, Janina
    Schneemann, Malte-Ole
    Schneider, Marc
    Hittinger, Marius
    PHARMACEUTICALS, 2023, 16 (05)
  • [44] Anti-Fatigue Effect of Green Tea Polyphenols (-)- Epigallocatechin-3-Gallate (EGCG)
    Teng, Yu-song
    Wu, Di
    PHARMACOGNOSY MAGAZINE, 2017, 13 (50) : 326 - 331
  • [45] Development of (-)-epigallocatechin-3-gallate (EGCG)-loaded enteric microparticles with intestinal mucoadhesive property
    Onoue, Satomi
    Ochi, Masanori
    Yamada, Shizuo
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 410 (1-2) : 111 - 113
  • [46] Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells
    Hazgui, Salma
    Bonnomet, Arnaud
    Nawrocki-Raby, Beatrice
    Milliot, Magali
    Terryn, Christine
    Cutrona, Jerome
    Polette, Myriam
    Birembaut, Philippe
    Zahm, Jean-Marie
    RESPIRATORY RESEARCH, 2008, 9 (1)
  • [47] Coadministration of epigallocatechin-3-gallate (EGCG) and caffeine in low dose ameliorates obesity and nonalcoholic fatty liver disease in obese rats
    Yang, Zhe
    Zhu, Ming-zhi
    Zhang, Yang-bo
    Wen, Bei-bei
    An, Hui-min
    Ou, Xing-chang
    Xiong, Yi-fan
    Lin, Hai-yan
    Liu, Zhong-hua
    Huang, Jian-an
    PHYTOTHERAPY RESEARCH, 2019, 33 (04) : 1019 - 1026
  • [48] Epigallocatechin-3-gallate (EGCG) inhibits myofibroblast transformation of human Tenon's fibroblasts
    Lin, Hong-Liang
    Qin, Yong-Jie
    Zhang, Yu-Lin
    Zhang, Yu-Qiao
    Chen, Yan-Lei
    Niu, Yong-Yi
    Pang, Chi-Pui
    Chu, Wai-Kit
    Zhang, Hong-Yang
    EXPERIMENTAL EYE RESEARCH, 2020, 197
  • [49] Identification of Epigallocatechin-3-Gallate (EGCG) from Green Tea Using Mass Spectrometry
    Sivanesan, Iyyakkannu
    Muthu, Manikandan
    Kannan, Anusha
    Pushparaj, Suraj Shiv Charan
    Oh, Jae-Wook
    Gopal, Judy
    SEPARATIONS, 2022, 9 (08)
  • [50] The specific anti-cancer activity of green tea (−)-epigallocatechin-3-gallate (EGCG)
    Y.-C. Wang
    U. Bachrach
    Amino Acids, 2002, 22 : 131 - 143